255 related articles for article (PubMed ID: 34290079)
21. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
22. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
[TBL] [Abstract][Full Text] [Related]
23. Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma.
Altinel K; Hashimoto K; Wei Y; Neuveut C; Gupta I; Suzuki AM; Dos Santos A; Moreau P; Xia T; Kojima S; Kato S; Takikawa Y; Hidaka I; Shimizu M; Matsuura T; Tsubota A; Ikeda H; Nagoshi S; Suzuki H; Michel ML; Samuel D; Buendia MA; Faivre J; Carninci P
J Virol; 2016 Dec; 90(23):10811-10822. PubMed ID: 27681123
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma and hepatitis B virus.
Chan HL; Sung JJ
Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
[TBL] [Abstract][Full Text] [Related]
25. The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data.
Li W; Goto K; Matsubara Y; Ito S; Muroyama R; Li Q; Kato N
PLoS One; 2015; 10(5):e0125555. PubMed ID: 25942596
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma.
Ke RS; Zhang K; Lv LZ; Dong YP; Pan F; Yang F; Cai QC; Jiang Y
Int J Biol Macromol; 2019 May; 129():140-151. PubMed ID: 30731163
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Gao F; Sun X; Wang L; Tang S; Yan C
Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
[TBL] [Abstract][Full Text] [Related]
28. Approaches for Detection of Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins and Their Application in Prediction of Higher Risk of Hepatocellular Carcinoma Development and Recurrence.
Lin YT; Jeng LB; Su IJ; Teng CF
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216021
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors.
Liu CJ; Kao JH
J Chin Med Assoc; 2007 Apr; 70(4):141-5. PubMed ID: 17475593
[TBL] [Abstract][Full Text] [Related]
30. HBV induced carcinogenesis.
Cougot D; Neuveut C; Buendia MA
J Clin Virol; 2005 Dec; 34 Suppl 1():S75-8. PubMed ID: 16461228
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
[TBL] [Abstract][Full Text] [Related]
32. Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.
Melis M; Diaz G; Kleiner DE; Zamboni F; Kabat J; Lai J; Mogavero G; Tice A; Engle RE; Becker S; Brown CR; Hanson JC; Rodriguez-Canales J; Emmert-Buck M; Govindarajan S; Kew M; Farci P
J Transl Med; 2014 Aug; 12():230. PubMed ID: 25141867
[TBL] [Abstract][Full Text] [Related]
33. Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure.
Xiang X; Qin HG; You XM; Wang YY; Qi LN; Ma L; Xiang BD; Zhong JH; Li LQ
Cancer Med; 2017 Oct; 6(10):2357-2369. PubMed ID: 28941211
[TBL] [Abstract][Full Text] [Related]
34. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
[TBL] [Abstract][Full Text] [Related]
36. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
[TBL] [Abstract][Full Text] [Related]
37. Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice.
McBrearty N; Arzumanyan A; Bichenkov E; Merali S; Merali C; Feitelson M
Neoplasia; 2021 May; 23(5):529-538. PubMed ID: 33945993
[TBL] [Abstract][Full Text] [Related]
38. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus infection and the risk of hepatocellular carcinoma.
Tan YJ
World J Gastroenterol; 2011 Nov; 17(44):4853-7. PubMed ID: 22171125
[TBL] [Abstract][Full Text] [Related]
40. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
